Yida Yuan

Title: Yida Yuan: Innovator in Cancer Treatment

Introduction

Yida Yuan is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on targeting specific mutations associated with various types of cancer.

Latest Patents

Yida Yuan holds a patent for "Nitrogen-containing heterocyclic derivatives, method therefor and application therefor as inhibitors of KRAS G12C for the treatment of cancers." This patent discloses a nitrogen-containing heterocyclic derivative regulator, along with its preparation method and application. The compound, represented by a general formula, is utilized as a KRAS G12C mutation inhibitor in the treatment of diseases such as leukemia, neuroblastoma, melanoma, breast cancer, lung cancer, and colon cancer. The definitions of substituents in the general formula are consistent with those provided in the patent description. He has 1 patent to his name.

Career Highlights

Yida Yuan has worked with notable companies in the pharmaceutical industry, including Jiangsu Hansoh Pharmaceutical Group Co., Ltd. and Shanghai Hansoh Biomedical Co., Ltd. His experience in these organizations has allowed him to contribute to the advancement of cancer therapies.

Collaborations

Yida Yuan has collaborated with esteemed colleagues such as Cheng Cen and Rudi Bao. These partnerships have fostered a collaborative environment that enhances innovation and research in cancer treatment.

Conclusion

Yida Yuan is a dedicated inventor whose work in developing targeted cancer therapies showcases his commitment to improving patient outcomes. His innovative approach and collaboration with industry professionals highlight the importance of research in the fight against cancer.